BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28073173)

  • 1. Expression of CD43 in chronic lymphoproliferative leukemias.
    Sorigue M; Juncà J; Sarrate E; Grau J
    Cytometry B Clin Cytom; 2018 Jan; 94(1):136-142. PubMed ID: 28073173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD43 in the malignant flow cytometry laboratory in 2020.
    Sorigue M
    Expert Rev Hematol; 2021 Jan; 14(1):123-136. PubMed ID: 33249940
    [No Abstract]   [Full Text] [Related]  

  • 3. Usefulness of the CLLflow score.
    Sorigue M; Franch-Sarto M; Sarrate E; Junca J
    Cytometry B Clin Cytom; 2018 Nov; 94(6):950-952. PubMed ID: 29316199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new score including CD43 and CD180: Increased diagnostic value for atypical chronic lymphocytic leukemia.
    Li Y; Tong X; Huang L; Li L; Wang C; He C; Liu S; Wang Z; Xiao M; Mao X; Zhang D
    Cancer Med; 2021 Jul; 10(13):4387-4396. PubMed ID: 34061467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of CD200 and CD43 Expression in Differential Diagnosis between Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma.
    Falay M; Afacan Öztürk B; Güneş K; Kalpakçı Y; Dağdaş S; Ceran F; Özet G
    Turk J Haematol; 2018 May; 35(2):94-98. PubMed ID: 28713070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [CD43 in B-cell chronic lymphocytic leukemia].
    Roliński J; Rupniewska ZM; Dmoszyńska A; Wasik-Szczepanek E; Bojarska-Junak A
    Pol Arch Med Wewn; 1999 Sep; 102(3):753-62. PubMed ID: 10949882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD200 Expression in Diagnostic and Prognostic Assessment of Mature B Cell Lymphophoproliferative Neoplasms.
    El Din Fouad NB; Ibrahim NY; Abdel Aziz RS; Ibrahim SK
    Asian Pac J Cancer Prev; 2018 Dec; 19(12):3383-3392. PubMed ID: 30583344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of CD43 and CD200 surface expression improves accuracy of B-cell lymphoma immunophenotyping.
    Hoffmann J; Rother M; Kaiser U; Thrun MC; Wilhelm C; Gruen A; Niebergall U; Meissauer U; Neubauer A; Brendel C
    Cytometry B Clin Cytom; 2020 Nov; 98(6):476-482. PubMed ID: 32716606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which Markers Should the used for Diagnostic Chronic Lymphocytic Leukemia Immunophenotyping Scoring System by Flow Cytometry?
    Falay M; Serdar MA; Dalgali H; Uçar MA; Dagdaş S; Özet G
    Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and phenotypic features of CD5-negative B cell chronic lymphoproliferative disease resembling chronic lymphocytic leukemia.
    Romano C; Sellitto A; Chiurazzi F; Simeone L; De Fanis U; Raia M; Del Vecchio L; Lucivero G
    Int J Hematol; 2015 Jan; 101(1):67-74. PubMed ID: 25432435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concordance between flow cytometry CLL scores.
    Sorigue M; Raya M; Vergara S; Junca J
    Int J Lab Hematol; 2021 Aug; 43(4):743-751. PubMed ID: 33949096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FMOD expression in whole blood aids in distinguishing between chronic lymphocytic leukemia and other leukemic lymphoproliferative disorders. A pilot study.
    Sorigue M; Junca J; Ferra C; Marce S; Ruiz-Xivillé N; Pinyol L; Cabezon M; Espasa A; Dominguez D; Lopez-Viaplana L; Ruiz R; Buch J; Plensa E; Mostacedo SZ; Aranda J; Vergara S; Raya M; Granada I; Tapia G; Navarro JT; Beà S; Zamora L
    Cytometry B Clin Cytom; 2020 Sep; 98(5):421-428. PubMed ID: 32530577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of CD200 expression and CD20 antibody binding capacity in differentiating chronic lymphocytic leukemia from other chronic lymphoproliferative disorders.
    Poongodi R; Varma N; Naseem S; Parveen B; Varma S
    Indian J Pathol Microbiol; 2018; 61(1):50-57. PubMed ID: 29567884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive predictive value of CD200 positivity in the differential diagnosis of chronic lymphocytic leukemia.
    Sorigue M; Magnano L; Miljkovic MD; Nieto-Moragas J; Santos-Gomez M; Villamor N; Junca J; Morales-Indiano C
    Cytometry B Clin Cytom; 2020 Sep; 98(5):441-448. PubMed ID: 31692239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunophenotyping of B chronic lymphoproliferative syndromes (CLL excluded): confrontation with the histology].
    El Borgi W; Ben Salah N; Ben Lakhal F; Makni L; Gouider E; Hafsia R
    Ann Biol Clin (Paris); 2013; 71(6):693-7. PubMed ID: 24342790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD43 and CD49d from the B-Cell Chronic Lymphoproliferative Disorders Diagnostic Panel Are Useful to Detect Erythroid Dysplasia.
    Oliveira M; Laranjeira P; Fortuna M; Bártolo R; Ribeiro A; Santos M; Cortesão E; Marques G; Sarmento-Ribeiro AB; Vitória H; Ribeiro L; Paiva A
    Cytometry B Clin Cytom; 2019 Sep; 96(5):417-425. PubMed ID: 31157955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consistency of the Moreau CLL score.
    Sorigue M; Sarrate E; Franch-Sarto M; Feliu E; Junca J
    J Clin Lab Anal; 2018 Jun; 32(5):e22376. PubMed ID: 29282771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refining the Limits of Borderline Lymphoproliferative Disorders.
    Sorigue M; Raya M; Vergara S; Sarrate E; Orna E; Juncà J
    Cytometry B Clin Cytom; 2019 Sep; 96(5):351-358. PubMed ID: 30592375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of CD5 in B-cell chronic lymphoproliferative diseases by flow cytometry: a strong expression in B-cell chronic lymphocytic leukemia.
    Cavalcanti Júnior GB; Sales VS; Cavalcanti e Silva DG; Lopes MC; Paiva Ade S; da Fonseca HE; do Nascimento Júniors FF; Fernandes MZ
    Acta Cir Bras; 2005; 20 Suppl 1():101-7. PubMed ID: 16186976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.